Skip to main content
logo
Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
10.51
+0.44 (4.37%)
At close: Aug 4, 2026, 4:00 PM EDT
10.40
-0.11 (-1.05%)
Pre-market: Aug 5, 2026, 4:32 AM EDT

Candel Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.130.13
Revenue Growth
----0%0%
Gross Profit
----0.130.13
Operating Income
-56.42-48.27-33.37-38.39-34.72-25.73
Net Income
-54.42-38.18-55.18-37.94-18.79-36.12
Earnings Per Share
-0.98-0.72-1.74-1.31-0.65-1.91
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
194.83119.73102.6535.4170.0682.64
Total Debt
49.2749.0313.4722.7622.80.56
Net Cash (Debt)
145.5670.789.1812.6547.2682.08
Net Cash Growth
79.15%-20.73%604.95%-73.23%-42.43%140.66%
Net Cash Per Share
2.601.332.820.441.644.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-47.73-38.31-27.02-34.24-31.42-22.22
Capital Expenditures
-1.26-0.59-0.02-0.46-1.3-1.84
Free Cash Flow
-48.99-38.9-27.04-34.7-32.72-24.05
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----100.00%100.00%
Operating Margin
-----27777.60%-20580.80%
Pretax Margin
-----15035.20%-28899.20%
Profit Margin
-----15035.20%-28899.20%
FCF Margin
-----26172.80%-19242.40%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----414.131794.84